A 40% reduction in prevalence is achievable with a non-waning vaccine of only 20% efficacy.
The reduction in prevalence of residual shunt with time tended to be greater when Gianturco coils were used (P =.067).
Further assessment of transmission-blocking potency ex vivo shows a dose-dependent response, with up to a 76.4% reduction in intensity and a 47.2% reduction in prevalence observed.
In intermediate and high transmission areas, reduction in prevalence is short-lived and the probability of local elimination is low, even at high coverage levels of the intervention.
We estimate that reductions in IPV combined with reduced witnessing by children when IPV did occur, led to a 64% reduction in prevalence of children witnessing IPV in their home (aRR 0.36, 95% CI 0.06 2.20).
This study showed that POHC administered by dental hygienists to a group of elderly patients needing daily nursing care was associated with a reduction in prevalence of fever and fatal pneumonia.
The reduction in prevalence of infection in LYSC-1 KD mosquitoes ranged from 33 72% relative to GFP controls.
The reduction in prevalence of vaccine-serotypes among adults clearly suggests a herd-protection effect.
Among the constituent disorders, somatoform disorder was most associated with the reduction in prevalence.
The reduction in prevalence rates was larger in areas with a stronger decrease in PM10 levels.
In Herd 2, the reduction in prevalence over time was evident in the treatment group.
